Internal Server Error

List of Cytiva's Acquisitions

lockFilter this list
Cytiva has completed a total of 4 acquisitions. Peak activity occurred in 2021 with 3 acquisitions and in 2022 with 1. Its acquisition activity spans 3 countries: Germany (2), United States (1), and Canada (1). Overall, the acquisitions involved 5 sectors, with notable activity in Genomics (2), Manufacturing Tech (1), and Life Sciences Tech (1). Over the last five years (2020–2025), the average number of acquisitions per year has been 0.8, with no acquisitions completed in the current calendar year. The most recent acquisition was Cevec Pharmaceuticals in October 2022, a Cologne-based provider of glyco-optimised human cell lines and gene therapy vectors using proprietary cell expression system, founded in 2001.

Recent acquisitions by Cytiva

Cytiva's most recent acquisition - Cevec Pharmaceuticals is a Provider of glyco-optimised human cell lines and gene therapy vectors using proprietary cell expression system, founded in 2001 and located in Cologne. Cytiva acquired it in October 2022 for a price of $*****.

Here is the list of all acquisitions by Cytiva sorted by the latest acquisition date:

Acquired on
Acquired Company
Acquisition Price
Facilitators
Stake Acquired
Acquisition Multiple
Oct 06, 2022
mocn
hbov
48
189
Jun 29, 2021
pnkl
ex{z
34
788
Jun 02, 2021
aghd
nutr
85
467

View the full list of acquisitions

Sign Up for Free

FAQs about Acquisitions by Cytiva

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford